期刊文献+

异常剪接组织因子在急性髓系白血病细胞株中的表达研究 被引量:3

Expression of Alternatively Spliced Human Tissue Factor in Acute Leukemia Cells
下载PDF
导出
摘要 急性白血病的出凝血异常和组织因子(tissue factor,TF)的高表达有关。循环血流中的TF主要表达于细胞、微粒(microparticle,MP)和异常剪接TF(alternatively spliced human tissue factor,asHTF)中。为探究asHTF在急性髓系白血病(acute myeloblastic leukemia,AML)出凝血异常中的作用,本研究选用了6种常见的AML细胞株NB4、HL-60、Kasumi-1、U937、K562和THP-1,在RNA水平进行了RT-PCR检测。结果发现,在6种细胞株中仅NB4、U937细胞存在全长TF和asHTF的RNA水平基线表达并经测序验证,对上述2种细胞在蛋白质水平进行了流式细胞仪及TF活性、抗原检测发现,asHTF仅有极少量TF抗原表达且基本无TF活性,而MP相关TF(microparticle associated tissue factor,MP-TF)的抗原和活性显著高于asHTF。结论:在NB4、U937细胞中asHTF基本无促凝作用,而MP-TF有凝血活性且在肿瘤细胞释放TF中占主导地位。 The high expression of tissue factor(TF) is related to the coagulation disorder in acute leukemia.TF in blood circulation is mainly expressed in cells,microparticles(MP) and alternatively spliced human tissue factor(asHTF).To elucidate the role of TF in the coagulation disorder of acute myeloid leukemia(AML),RT-PCR was performed on 6 common AML cell lines NB4,HL-60,Kasumi-1,U937,K562 and THP-1.The results showed that only NB4 and U937 cells expressed baseline full-length TF and asHTF which were proved by sequencing.The flow cytometric detection,TF activity and TF antigen tests in NB4 and U937 cells revealed that the asHTF was expressed in trace amount and almost had no activity,while the TF antigen and activity in microparticles were significantly higher than that in asHTF.It is concluded that asHTF may play an unimportant role in the coagulation disorder of AML.Microparticle associated tissue factor(MP-TF) is the predominant source of TF activity released from AML cells.
出处 《中国实验血液学杂志》 CAS CSCD 2011年第2期288-292,共5页 Journal of Experimental Hematology
基金 国家自然科学基金资助项目(编号30801062)
关键词 急性髓系白血病 组织因子 异常剪接组织因子 微粒 acute myeloid leukemia tissue factor alternatively spliced human tissue factor microparticle
  • 相关文献

参考文献11

  • 1Nadir Y, Katz T, Sarig G, et al. Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptor. Haematologica, 2005; 90 ( 11 ) : 1549 - 1556.
  • 2Bogdanov VY, Balasubramanian V, Hathcock J, et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med,2003 ;9(4 ) :458 -462.
  • 3Zhu J, Guo WM, Yao YY, et aL Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia, 1999 ; 13 (7) : 1062 - 1070.
  • 4Poitevin S, Cochery-Nouvellon E, Dupont A, et al. Monocyte/L- 10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles. Thromb Haemost,2007 ;97(4) : 598 - 607.
  • 5Szotowski B, Antoniak S, Poller W, et al. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res,2005,96(12) :1233 -1239.
  • 6Censarek P, Bobbe A, Grandoch M, et al. Altemativly spliced human tissue factor (asHTF) is not procoagulant. Thromb Haemost,2007 ; 97 ( 1 ) : 11 - 14.
  • 7Hobbs JE, Zakarija A, Cundiff DL, et al. Altemativly spliced human tissue factor promotes tumor growth and anguigenesis in a pancreatic cancer tumor model. Thromb Res, 2007 ;120 ( Suppl 2) : S13 -21.
  • 8Signaevsky M, Hobbs J, Doll J, et al. Role of altemativly spliced human tissue factor in pancreatic cancer growth and angiogenesis. Semin Thromb Hemost,2008;34(2) :161 - 169.
  • 9Yu JL, Rak JW. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J Thromb Haemost ,2004 ;2 ( 11 ) : 2065 - 2067.
  • 10Tesselaar ME, Romijn FP, Van Der Linden IK, et al. Microparticle-associated tissue factor activity: a link between cancer and thrombosis. J Thromb Haemost, 2007 ;5 ( 3 ) : 520 - 527.

同被引文献29

  • 1Giesen PL, Ranch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis[J]. Proc Natl Acad Sci USA, 1999,96 (5) :2311-2315.
  • 2Bogdanov VY, Balasubramanian V, Hathcock J, et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein[J]. Nat Med,2003,9(4) :458-462.
  • 3Hobbs JE, Zakarija A, Cundiff DL, et al. Alternatively spliced hu- man tissue factor promotes tumor growth and angiogencsis in a pan- creatic cancer tumor model [ J ]. Thromb Res, 2007,120 (Suppl 2 ) : S13-S21.
  • 4van den Berg YW, van den Hengel LG, Myers HR, et al. Alterna- tively spliced tissue factor induces angiogenesis through integrin liga- tion[ J]. Proc Natl Acad Sci USA ,2009,106 (46) : 19497-19502.
  • 5Szotowski B, Goldin-Lang P, Antoniak S, et al. Alterations in myo- cardial tissue factor expression and cellular localization in dilated car- diomyopathy[ J]. J Am Coll Cardiol,2005,45(7) :1081-1089.
  • 6Tardos JG, Eisenreich A, Deikus G, et al. SR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human mono- cytic cells[ J]. J Thromb Haemost,2008,6(5 ) :877-884.
  • 7Mackman N. Regulation of the tissue factor gene[ J]. FASEB J, 1995,9(10) :883-889.
  • 8van den Berg YW, Versteeg HH. Alternatively spliced tissue fac- tor. A crippled protein in coagulation or a key player in non-haemo- static processes.? [J]. Hamostaseologie,2010,30 (3) : 144-149.
  • 9LEROYER A S, TEDGUI A, BOULANGER C M. Role of mieroparticles in atherothrombosis[J]. J Intern Med, 2008,263 .. 528- 537.
  • 10ZWICKER J I, TRENOR C C, FURIE B C, et al. Tis- sue factor bearing-microparticles and thrombus forma- tion[J]. Arterioscler Thromb Vase Biol, 2011, 31.. 728-733.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部